HIV gene amplification meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA will hold a public meeting Sept. 26-28 in Silver Spring, Maryland to consider "the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative 'window' phase" of HIV infection, according to an Aug. 1 Federal Register notice. Topics to be discussed include the current status of techniques "for the detection of genetic sequences by amplification" and their applicability to donor screening, as well as "procedural and economic aspects" of utilizing these techniques. For more information, contact Nicholas Reuter at 301/443-1382
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.